Merck
CN
Search Within
文件类型

216-521-3

应用筛选条件
关键词:'216-521-3'
显示 1-15 共 15 条结果 关于 "216-521-3" 范围 技术文档
XP725 Antibody Number-Lot Number 071M4826
277 278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284 3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288 4.1 289 290 291 292
Product Information Sheet - SE120084
N.W. ed., Clinical Guide to Laboratory Tests, 3rd Edition, W.B. Saunders, Co., Philadelphia, 1995: 216-217. 18. USA Center for Disease Control/National Institute of Health Manual, “Biosafety in Microbiological
Product Information Sheet - SE120049
., Clinical Guide to Laboratory Tests, 3rd Edition, W.B. Saunders, Co., (Philadelphia, PA: 1995) 216-217. 18. USA Center for Disease Control/National Institute of Health Manual, “Biosafety in Microbiological
Principles of Steam-In-Place
kg/h vs piping size in mm in barg in m/s 15 20 25 32 40 50 65 80 100 0.5 20 10 20 32 57 77 126 216 301 513 30 16 30 47 85 116 189 324 451
XP725 Antibody List Lot 129K4831
Marker C5867 NA NA M y n/d n/d 192 Anti Cy3+Cy5 C0992 NA NA M 212 Pan Cytokeratin C2931 NA NA M y y y 216 Anti Cy3+Cy5 C0992 NA NA M 225 Dnase I D0188 NA NA P n/d n/d n/d 240 Anti Cy3+Cy5
XP725 Antibody List Lot 129K4830
Marker C5867 NA NA M y n/d n/d 192 Anti Cy3+Cy5 C0992 NA NA M 212 Pan Cytokeratin C2931 NA NA M y y y 216 Anti Cy3+Cy5 C0992 NA NA M 225 Dnase I D0188 NA NA P n/d n/d n/d 240 Anti Cy3+Cy5
XP725 Antibody List Lot 089K4791
Marker C5867 NA NA M y n/d n/d 192 Anti Cy3+Cy5 C0992 NA NA M 212 Pan Cytokeratin C2931 NA NA M y y y 216 Anti Cy3+Cy5 C0992 NA NA M 225 Dnase I D0188 NA NA P n/d n/d n/d 240 Anti Cy3+Cy5
List of Antibodies
D2178 M y n/d n/d 214 phospho-DAPK (pSer308) D4941 M y n/d n/d 215 DAP Kinase 2 D3191 P y y y 216 Anti Cy3+Cy5 C0992 M NA NA NA 217 Daxx D7810 P y n/d n/d 218 DcR1 D3566 P y y y 219
XP725 Antibody List
DAP Kinase 2 D3191 23604, 13143, 300799 DAPK2,Dapk2 NP_055141.2,NP_034149.2,NP_001013127.1 P y y y 216 Anti Cy3+Cy5 217 Daxx D7810 13163, 1616 DAXX,Daxx NP_031855.3,NP_001341.1 P y n/d n/d 218 DcR1 D3566
Halal Certificate
. 3,4-HEXANEDIONE 90% W316814 A55482 HC-23SIUP10 215. 3,4-XYLENOL W359602 C51542 HC-23SIQ783 216. 3,5,5-TRIMETHYLHEXANAL 95%, FG W352403 A12153 HC-23SI3622 This is to certify that the following
Halal Certificate
. 3,4-HEXANEDIONE 90% W316814 A55482 HC-22SIE131 215. 3,4-XYLENOL W359602 C51542 HC-22SICX05 216. 3,5,5-TRIMETHYLHEXANAL 95%, FG W352403 A12153 HC-22SI5N43 This is to certify that the following
XP725 Worksheet for Lot Number 071M4826
E1531 517 3 3 5 5 Ezrin E8897 518 3 3 5 6 Ezrin E8897 519 3 3 5 7 F1A F3428 520 3 3 5 8 F1A F3428 521 3 3 6 1 FADD F8053 522 3 3 6 2 FADD F8053 523 3 3 6
XP725 Antibody List 013M4793
DAP Kinase 2 D3191 23604, 13143, 300799 DAPK2,Dapk2 NP_055141.2,NP_034149.2,NP_001013127.1 P y y y 216 Anti Cy3+Cy5 C0992 217 Daxx D7810 13163, 1616 DAXX,Daxx NP_031855.3,NP_001341.1 P y n/d n/d 218 DcR1
3D BIOPRINTING: Printing a Brighter Future
hydroxyapatite, can also be used to make composite GelMA bioinks with tuned mechanical properties.216–219 In addition, multi-walled carbon nanotubes (MWCNTs) have also been added to GelMA to enhance
3D BIOPRINTING: Printing a Brighter Future
hydroxyapatite, can also be used to make composite GelMA bioinks with tuned mechanical properties.216–219 In addition, multi-walled carbon nanotubes (MWCNTs) have also been added to GelMA to enhance